Get the tools used by (smart)2 investors.

Viatris IncNASDAQGS:VTRS

United States / Healthcare / Pharmaceuticals

Join now and get access to the full platform

Exchange Data

Hide this widget
7.57 USD
Price
0.01 (0.13%)
Day change
6.85 - 13.55
52-week range

Summary of Viatris Inc

Hide this widget

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, N...

Dec 31, 2024
Latest Report
May 8, 2025
Next Earnings
Filings

Price History

Chart Gallery
Hide this widget
Loading chart...

Data could not be retrieved

Data Explorer

Hide this widget

Peer Benchmarks

Hide this widget
  VTRS Peers Sector
Market Cap
9.024 B2.868 B64.048 M
Price % of 52 Week High
55.8%48.1%60.4%
Dividend Yield
6.3%0.0%0.0%
Shareholder Yield
54.9%5.1%-0.7%
1 Year Price Total Return
-29.8%18.8%-12.3%
Beta (5 Year)
0.910.690.64

Finbox Fair Value

Hide this widget
What is Finbox Fair Value?
A stock's fair value is its real or underlying intrinsic worth.
Read more about Finbox's Fair Value methodology.
USD
Average
Upside
Uncertainty
You need an account to use this feature
Sign Up
Or
Log In

Financial Health

Health Details
Hide this widget
GOOD
Financial Health for Viatris is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.

Financial Models for Viatris Inc

Model Gallery
Hide this widget

Historical Financials

Full Financials
Hide this widget
(presentment in millions)Trailing Twelve MonthsFiscal Quarters
Period EndingDec-22Dec-23Dec-24Dec-23Dec-24
Income Statement
Revenue16,26315,42714,7393,8373,528
Operating Income2,7472,1541,775511453
Net Profit2,07955(634)(766)(517)
Diluted EPS1.710.046-0.53-0.64-0.43
EBITDA5,6014,8344,4831,0941,014
Balance Sheet
Cash & ST Invest.1,4731,1841,0901,1841,090
Current Assets10,63512,9769,52112,9769,521
Total Assets50,02247,68641,50147,68641,501
Current Liabilities6,7467,7775,7797,7775,779
Total Liabilities28,95027,21822,86527,21822,865
Total Equity21,07220,46718,63620,46718,636
Total Debt19,52818,37114,30618,37114,306
Cash Flow Statement
Cash Flow Operations2,9992,9002,303569483
Cash From Investing1,474(865)1,80127(169)
Cash From Financing(3,878)(2,302)(4,330)(926)(1,420)
Free Cash Flow2,5932,5231,977403342

Analyst Notes

April 21, 2025
Hide this widget
    All rights reserved. Terms Of Use